Get startedLog in
    Picture of Regulus Therapeutics logo

    RGLS — Regulus Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Brief: Regulus Therapeutics Reports Fourth Quarter And Year-End 2021 Financial Results And Recent Updates

    Picture of Regulus Therapeutics logoRegulus Therapeutics
    10/03/2022 22:16
    March 10 (Reuters) - Regulus Therapeutics Inc  RGLS.O :
    * REGULUS THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END
2021
FINANCIAL RESULTS AND RECENT UPDATES
    * Q4 LOSS PER SHARE $0.07
    * AS OF DECEMBER 31, 2021, REGULUS HAD $60.4 MILLION IN CASH
AND
CASH EQUIVALENTS

Source text for Eikon:  ID:nPn9jdrNWa 
Further company coverage:  RGLS.O

    Recent news on Regulus Therapeutics

    See all news